找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cardiac Arrhythmias: New Therapeutic Drugs and Devices; Proceedings of the S Joel Morganroth,E. Neil Moore Conference proceedings 1985 Mart

[复制链接]
楼主: Malnutrition
发表于 2025-3-28 16:23:25 | 显示全部楼层
Is There a Rational Basis for the Modified Classification of Antiarrhythmic Drugs?ties, their electrophysiologic properties in the intact heart (where studies could determine thresholds of conduction), and their clinical use in specific syndromes. Most of these attempts did not increase our knowledge of antiarrhythmic drugs or their clinical application. Since quinidine, introduc
发表于 2025-3-28 21:42:02 | 显示全部楼层
发表于 2025-3-29 01:26:34 | 显示全部楼层
Mexiletine, Tocainide and Ethmozine: Newer Class I Antiarryhthmic Agentsesults in impaired conduction velocity in myocardial tissue.. Overall clinical antiarrhythmic efficacy in this group is dependent upon the ability of these agents to alter conduction and refractoriness, and suppress diastolic depolarization, thereby interfering with reentrant circuits and suppressin
发表于 2025-3-29 06:33:53 | 显示全部楼层
Class IC Antiarrhythmic Agents: Status — 1984ysfunction can be identified as being at high risk for sudden cardiac death, protocols have been implemented to determine whether this endpoint can be eliminated. The group of antiarrhythmic agents, which are known as Vaughan Williams Class IC agents have demonstrated particularly unique clinical ch
发表于 2025-3-29 09:34:08 | 显示全部楼层
发表于 2025-3-29 12:26:14 | 显示全部楼层
Status of Class III Antiarrhythmic Drugs: Amiodarone, Bretylium and SotalolIn addition to their pharmacologic property of prolonging myocardial repolarization they were all introduced for clinical use and study for indications unrelated to cardiac arrhythmias. Therefore, it is important to remember that their development was not guided by the intention to develop an ideal
发表于 2025-3-29 18:05:58 | 显示全部楼层
发表于 2025-3-29 22:17:49 | 显示全部楼层
Sudden Cardiac Death — Failure or Effect of Antiarrhythmic Drug Therapy?units. and from chance events captured on dynamic ECG recorders. show that ventricular tachyarrhythmias (ventricular tachycardia, ventricular flutter and ventricular fibrillation) are the commonest arrhythmias implicated.
发表于 2025-3-30 03:23:37 | 显示全部楼层
Sudden Death as an End-Point for the Clinical Evaluation of Antiarrhythmic Drugshythmia induced death rather than alleviating symptomatology. The major dilemma facing the clinician is that the use of easily quantifiable total or partial pharmacologic suppression of ventricular arrhythmia during a period of electrocardiographic monitoring has not been shown to be associated with
发表于 2025-3-30 06:43:59 | 显示全部楼层
Holter/Exercise and Electrophysiologic Methods for Evaluating Drug Therapy for Malignant Ventricularbrillation (VF). Routine clinical evaluation usually reveals ample evidence for the existence of heart disease in patients with these arrhythmias. Coronary heart disease is by far the most frequently occurring etiologic form of heart disease (about 80%) followed by cardiomyopathy and valvular heart
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 08:18
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表